Doi K - Search Results

1

Common variation in GPC5 is associated with acquired nephrotic syndrome.

Okamoto K, Tokunaga K, Doi K, Fujita T, Suzuki H, Katoh T, Watanabe T, Nishida N, Mabuchi A, Takahashi A, Kubo M, Maeda S, Nakamura Y, Noiri E. Okamoto K, et al. Among authors: doi k. Nat Genet. 2011 May;43(5):459-63. doi: 10.1038/ng.792. Epub 2011 Mar 27. Nat Genet. 2011. PMID: 21441931

2

Mannitol-induced acute renal failure.

Doi K, Ogawa N, Suzuki E, Noiri E, Fujita T. Doi K, et al. Am J Med. 2003 Nov;115(7):593-4. doi: 10.1016/s0002-9343(03)00425-x. Am J Med. 2003. PMID: 14599652 No abstract available.

3

High-throughput single nucleotide polymorphism typing by fluorescent single-strand conformation polymorphism analysis with capillary electrophoresis.

Doi K, Doi H, Noiri E, Nakao A, Fujita T, Tokunaga K. Doi K, et al. Among authors: doi h. Electrophoresis. 2004 Mar;25(6):833-8. doi: 10.1002/elps.200305721. Electrophoresis. 2004. PMID: 15004843

4

Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.

Doi K, Suzuki Y, Nakao A, Fujita T, Noiri E. Doi K, et al. Kidney Int. 2004 May;65(5):1714-23. doi: 10.1111/j.1523-1755.2004.00567.x. Kidney Int. 2004. PMID: 15086910 Free article.

5

The association of NAD(P)H oxidase p22phox with diabetic nephropathy is still uncertain: response to Hodgkinson, Millward, and Demaine.

Doi K, Noiri E, Tokunaga K. Doi K, et al. Diabetes Care. 2004 Jun;27(6):1518-9; author reply 1519. doi: 10.2337/diacare.27.6.1518. Diabetes Care. 2004. PMID: 15161815 No abstract available.

6

Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease.

Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K. Doi K, et al. J Hum Genet. 2005;50(12):641-7. doi: 10.1007/s10038-005-0310-4. Epub 2005 Oct 8. J Hum Genet. 2005. PMID: 16215641

7

Pulse total-hemoglobinometer provides accurate noninvasive monitoring.

Noiri E, Kobayashi N, Takamura Y, Iijima T, Takagi T, Doi K, Nakao A, Yamamoto T, Takeda S, Fujita T. Noiri E, et al. Among authors: doi k. Crit Care Med. 2005 Dec;33(12):2831-5. doi: 10.1097/01.ccm.0000190430.96750.51. Crit Care Med. 2005. PMID: 16352948 Clinical Trial.

8

Non-association of VEGF genetic polymorphisms in promoter--5' UTR with end-stage renal disease.

Doi K, Noiri E, Fujita T, Tokunaga K. Doi K, et al. Nephrol Dial Transplant. 2006 Apr;21(4):1124-5; author reply 1125. doi: 10.1093/ndt/gfk100. Epub 2006 Jan 18. Nephrol Dial Transplant. 2006. PMID: 16421153 No abstract available.

9

Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males.

Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K. Doi K, et al. J Am Soc Nephrol. 2006 Mar;17(3):823-30. doi: 10.1681/ASN.2005010094. Epub 2006 Jan 18. J Am Soc Nephrol. 2006. PMID: 16421229

10

Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, Fujita T, Toda A, Yokomizo T, Kita Y, Kihara Y, Ishii S, Shimizu T, Noiri E. Doi K, et al. Am J Pathol. 2006 May;168(5):1413-24. doi: 10.2353/ajpath.2006.050634. Am J Pathol. 2006. PMID: 16651609 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,621 results

Search Page